Literature DB >> 11861535

Anti-Müllerian hormone inhibits initiation of primordial follicle growth in the mouse ovary.

Alexandra L L Durlinger1, Maria J G Gruijters, Piet Kramer, Bas Karels, Holly A Ingraham, Mark W Nachtigal, Jan Th J Uilenbroek, J Anton Grootegoed, Axel P N Themmen.   

Abstract

Recruitment of primordial follicles is essential for female fertility; however, the exact mechanisms regulating this process are largely unknown. Earlier studies using anti-Müllerian hormone (AMH)-deficient mice suggested that AMH is involved in the regulation of primordial follicle recruitment. We tested this hypothesis in a neonatal ovary culture system, in which ovaries from 2-d-old C57Bl/6J mice were cultured for 2 or 4 d in the absence or presence of AMH. Ovaries from 2-d-old mice contain multiple primordial follicles, some naked oocytes, and no follicles at later stages of development. We observed that in the cultured ovaries, either nontreated or AMH-treated, follicular development progressed to the same extent as in in vivo ovaries of comparable age, confirming the validity of our culture system. However, in the presence of AMH, cultured ovaries contained 40% fewer growing follicles compared with control ovaries. A similar reduction was found after 4 d of culture. Consistent with these findings, we noted lower inhibin alpha-subunit expression in AMH-treated ovaries compared with untreated ovaries. In contrast, expression of AMH ligand type II receptor and the expression of oocyte markers growth and differentiation factor 9 and zona pellucida protein 3 were not influenced by AMH. Based on the results, we suggest that AMH inhibits initiation of primordial follicle growth and therefore functions as an inhibitory growth factor in the ovary during these early stages of folliculogenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11861535     DOI: 10.1210/endo.143.3.8691

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  168 in total

Review 1.  Epigenetic effects of endocrine-disrupting chemicals on female reproduction: an ovarian perspective.

Authors:  Aparna Mahakali Zama; Mehmet Uzumcu
Journal:  Front Neuroendocrinol       Date:  2010-07-04       Impact factor: 8.606

Review 2.  Fertility Preservation in Women with Turner Syndrome: A Comprehensive Review and Practical Guidelines.

Authors:  Kutluk Oktay; Giuliano Bedoschi; Karen Berkowitz; Richard Bronson; Banafsheh Kashani; Peter McGovern; Lubna Pal; Gwendolyn Quinn; Karen Rubin
Journal:  J Pediatr Adolesc Gynecol       Date:  2015-10-17       Impact factor: 1.814

3.  Speciation and reduced hybrid female fertility in house mice.

Authors:  Taichi A Suzuki; Michael W Nachman
Journal:  Evolution       Date:  2015-09-08       Impact factor: 3.694

Review 4.  Developmental exposure to environmental endocrine disruptors: consequences within the ovary and on female reproductive function.

Authors:  Mehmet Uzumcu; Rob Zachow
Journal:  Reprod Toxicol       Date:  2006-11-06       Impact factor: 3.143

Review 5.  Progress in understanding human ovarian folliculogenesis and its implications in assisted reproduction.

Authors:  Dong Zi Yang; Wan Yang; Yu Li; Zuanyu He
Journal:  J Assist Reprod Genet       Date:  2013-02       Impact factor: 3.412

6.  Role for androgens in determination of ovarian fate in the common snapping turtle, Chelydra serpentina.

Authors:  Anthony Schroeder; Turk Rhen
Journal:  Gen Comp Endocrinol       Date:  2019-05-03       Impact factor: 2.822

7.  Antimüllerian hormone and antral follicle count are lower in female cancer survivors and healthy women taking hormonal contraception.

Authors:  Lauren N C Johnson; Mary D Sammel; Katherine E Dillon; Lara Lechtenberg; Allison Schanne; Clarisa R Gracia
Journal:  Fertil Steril       Date:  2014-06-14       Impact factor: 7.329

8.  Inhibition of vascular endothelial growth factor receptor signal transduction blocks follicle progression but does not necessarily disrupt vascular development in perinatal rat ovaries.

Authors:  Renee M McFee; Robin A Artac; Ryann M McFee; Debra T Clopton; Robyn A Longfellow Smith; Timothy G Rozell; Andrea S Cupp
Journal:  Biol Reprod       Date:  2009-07-15       Impact factor: 4.285

Review 9.  Regulation of the ovarian reserve by members of the transforming growth factor beta family.

Authors:  Stephanie A Pangas
Journal:  Mol Reprod Dev       Date:  2012-09-11       Impact factor: 2.609

10.  Continuous treatment with cisplatin induces the oocyte death of primordial follicles without activation.

Authors:  Maya Eldani; Yi Luan; Pauline C Xu; Tom Bargar; So-Youn Kim
Journal:  FASEB J       Date:  2020-08-23       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.